Pandolfi, Franco
 Distribuzione geografica
Continente #
NA - Nord America 3.014
EU - Europa 2.646
AS - Asia 618
SA - Sud America 17
OC - Oceania 16
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.316
Nazione #
US - Stati Uniti d'America 2.994
DE - Germania 790
SE - Svezia 511
UA - Ucraina 489
CN - Cina 426
IE - Irlanda 210
IT - Italia 197
FR - Francia 162
FI - Finlandia 113
GB - Regno Unito 77
IN - India 75
TR - Turchia 27
JP - Giappone 23
BE - Belgio 19
AU - Australia 15
PL - Polonia 15
SG - Singapore 15
CA - Canada 14
HK - Hong Kong 13
IR - Iran 10
RU - Federazione Russa 10
VN - Vietnam 10
CH - Svizzera 9
NL - Olanda 9
ES - Italia 7
AR - Argentina 6
CL - Cile 6
IL - Israele 4
MK - Macedonia 4
MX - Messico 4
RO - Romania 4
BR - Brasile 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
KR - Corea 3
RS - Serbia 3
AT - Austria 2
ID - Indonesia 2
IS - Islanda 2
MY - Malesia 2
NO - Norvegia 2
PH - Filippine 2
PT - Portogallo 2
RE - Reunion 2
SA - Arabia Saudita 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
EU - Europa 1
HU - Ungheria 1
KW - Kuwait 1
NZ - Nuova Zelanda 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
ZA - Sudafrica 1
Totale 6.316
Città #
Chandler 515
Ashburn 335
Jacksonville 251
San Mateo 204
Dublin 202
Wilmington 118
Ann Arbor 108
Nanjing 107
Lawrence 86
Boston 79
Cattolica 72
Dearborn 67
Houston 56
Beijing 52
Woodbridge 52
Fairfield 47
Redwood City 46
Boardman 42
Seattle 41
Marseille 34
Nürnberg 33
Mountain View 32
New York 32
Nanchang 31
Shenyang 30
University Park 30
Hebei 29
Lancaster 29
Detroit 27
Hangzhou 27
Princeton 23
Izmir 21
Milan 21
Bremen 19
Cambridge 19
Chicago 19
Norwalk 19
Jiaxing 18
Brussels 17
Changsha 17
Helsinki 16
Rome 16
Munich 14
Shanghai 14
Kraków 13
Tianjin 13
Zhengzhou 13
Jinan 12
Washington 12
Los Angeles 11
Fremont 10
Hanoi 10
Hefei 10
Pune 10
Guangzhou 9
Kunming 9
Leawood 9
Simi Valley 9
Busto Arsizio 8
Hong Kong 8
Singapore 8
Bareggio 7
Encino 7
Zola Predosa 7
Bern 6
Edinburgh 6
Falls Church 6
Kish 6
Philadelphia 6
Ypsilanti 6
Indiana 5
Ningbo 5
Verona 5
Augusta 4
Chengdu 4
London 4
Montréal 4
Prilep 4
Sydney 4
Tappahannock 4
Ankara 3
Atlanta 3
Barrie 3
Bilbao 3
Fuzhou 3
Norfolk 3
Padova 3
Port Orchard 3
Raleigh 3
San Francisco 3
San Giorgio del Sannio 3
Serooskerke 3
Taizhou 3
Tokyo 3
Ashland 2
Bangalore 2
Belgrade 2
Berlin 2
Caserta 2
Changchun 2
Totale 3.395
Nome #
Can vitamin a mediate immunity and inflammation? 120
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 105
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 104
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 102
Key Role of DAMP in Inflammation, Cancer, and Tissue Repair 99
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 99
Role of vitamins D, E and C in immunity and inflammation. 99
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. 96
Reflux symptoms in wind instrument players. 95
Uncomplicated Diverticular Disease: Innate and Adaptive Immunity in Human Gut Mucosa before and after Rifaximin 94
How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology 94
Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. 93
Common variable immunodeficiency - new insight into the pathogenesis and the quest for a workable classification. 85
The immune response to tumors as a tool toward immunotherapy 84
Central and Mucosal Immunities are Modified by Non Adsorbable Antibiotic Treatment in Uncomplicated Diverticular Disease 84
T-cell receptor repertoire and function in patients with Di George Syndrome and velocardiofacial syndrome. 83
Third-line rescue therapy for Helicobacter pylori infection 81
IL-32: a newly-discovered proinflammatory cytokine 80
TLR2: a crossroads between infections and autoimmunity? 80
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 80
The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop 78
Third-line rescue therapy for Helicobacter pylori infection. 76
Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration 76
The importance of complying with vaccination protocols in developed countries: "anti-vax" hysteria and the spread of severe preventable diseases 76
Allele*1 of HS1,2 enhancer associates with selective IgA deficiency and IgM concentration 75
Luteolin inhibits mast cell-mediated allergic inflammation. 73
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system 69
New insights on the role of T-cels in the pathogenesis of Celiac Disease 69
Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. 69
Cellular mediators of inflammation: tregs and t(h)17 cells in gastrointestinal diseases. 69
Impairment of recent thymic emigrants in HCV infection. 68
The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial disease 67
Interleukin-6 in Rheumatoid Arthritis 67
Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART 65
Increased osteoclastic activity in acute Charcot's osteoarthopathy: the role of receptor activator of nuclear factor-kappa B ligand 65
New insights on the role of T cells in the pathogenesis of celiac disease. 64
Strategies to overcome obstacles to successful immunotherapy of melanoma 62
BALKAN ENDEMIC NEPHROPATHY RISK ASSOCIATES TO THE HS1.2 IG ENHANCER POLYMORPHISM 62
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. 61
Melanoma antigen recognition by tumor-infiltrating T lymphocytes (TIL): effect of differential expression of melan-A/MART-1 60
Impact of IL-18 on inflammation 60
Apoptosis in asymptomatic HIV-1 seropositives immunized with HIV-1 env glycoprotein (gp160): effects of administration of Zidovudine in vivo and IL-2 in vitro 60
The impact of biological agents interfering with receptor/ligand binding in the immune system. 59
Activity of caffeic acid derivatives against Candida albicans biofilm 59
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 58
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 57
VEGF, substance P and stress, new aspects: a revisited study. 56
TLR2: a crossroads between infections and autoimmunity? 55
Mast cell involvement in rheumatoid arthritis. 54
Current Challenges in Immunology 54
Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer. 54
Impact of Fungi on Immune Responses 54
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 54
Abnormal synthesis of IgA in coeliac disease and related disorderd 53
Apoptosis in the homeostasis of the immune system and in human immune mediated diseases 51
Tissue infiltrating lymphocytes: the role of cytokines in their growth and differentiation. 51
Vitamins and mast cells. 51
The number of HIV-DNA infected mononuclear cells is reduced under HAART plus recombinant IL-2. 50
Strategies to overcome obstacles to successful immunotherapy of melanoma. 50
Integrins: Integrating the Biology and Therapy of Cell-cell Interactions 50
Mast Cells Mediate Rheumatoid Arthritis-Inhibitory Role of IL-37 50
The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group 49
IL-31 a Th2 cytokine involved in immunity and inflammation. 49
Involvment of central immunity in uncomplicated diverticular disease. 49
Nutrition and cancer prevention 49
Luteolin, inflammation and cancer: Special emphasis on gut microbiota 49
Induction of "antigen silencing" in melanomas by oncostatin M: downmodulation of melanocyte antigen expression. 48
Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2. 48
High prevalence of hyperplastic colonic polyps in acromegalic subjects. 48
Heat shock protein-90 inhibitors enhance antigen expression on melanomas and increase T cell recognition of tumor cells 48
A novel autocrine pathway of tumor escape immune recognition; melanoma cell produce a soluble protein that diminuishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down modulation of its promoter. 47
Active thymopoiesis in idiopathic chronic pancreatitis 47
Comparison of beneficial actions of non-steroidal anti-inflammatory drugs to flavonoids 47
IgE generation and mast cell activation 47
Epatite da farmaci 45
Impact of mast cells in rejection of allografts 45
Biased T cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (Di George syndrome/velocardiofacial syndrome) 44
Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes 44
HCV co-infection does not affect the TREC/IL-7 pathway in HIV disease 44
HIV type 1-induced inhibition of CD45 tyrosine phosphatase activity correlates with disease progression and apoptosis, but not with anti-CD3-induced T cell proliferation 43
Interrelationship between IL-3 and mast cells 43
Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines 43
New insight into systemic mastocytosis mediated by cytokines IL-1 beta and IL-33: Potential inhibitory effect of IL-37 43
Structure and expression of the human ubiquitin fusion-degradation gene (UFD1L). 42
Nickel allergy in lipid transfer protein sensitized patients: Prevalence and clinical features 42
Apoptotic effect of cyclosporin a and dexamethasone in malignant cells of patients with B-chronic lymphocytic leukemia. 41
Impact of capsaicin on mast cell inflammation. 41
Nerve growth factor interactions with mast cells 41
Decreased CD 95 expression on naive T cells from HIV infected persons undergoing highly active antiretroviral therapy (HAART) and the influence of IL-2 low dose administration 40
Role of mast cells in innate and adaptive immunity. 40
Vascular endothelial growth factor (VEGF), mast cells and inflammation. 40
VEGF, substance P and stress, new aspects: a revisited study 40
Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease 40
Impact of mast cells on the skin. 39
IL-36 receptor antagonist with special emphasis on IL-38. 38
Oligoclonality of Vdelta1 and Vdelta2 cells in human peripheral blood mononuclear cells: TCR selection is not altered by stimulation with gram-negative bacteria 36
Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation 36
Impact of immunity in autism spectrum disorders 36
Impact of IL -9 and IL-33 in mast cells 36
Neuropeptide NGF mediates neuro-immune response and inflammation through mast cell activation 36
Totale 6.051
Categoria #
all - tutte 24.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.145


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019117 0 0 0 0 0 0 0 0 0 30 33 54
2019/2020749 193 20 40 18 27 54 77 28 37 31 107 117
2020/2021973 51 104 13 108 132 76 129 24 111 16 182 27
2021/2022857 65 125 14 62 46 32 11 118 38 44 116 186
2022/20231.573 229 181 152 207 155 201 55 94 166 42 60 31
2023/2024715 30 279 23 129 27 100 23 44 21 39 0 0
Totale 6.376